Canada· CA-DIN-00009881
PAPAVERINE HYDROCHLORIDE INJECTION USP
A papaverine product containing papaverine hydrochloride, registered in Canada by SANDOZ CANADA INCORPORATED. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Papaverine is registered in 9 of 19 countries.
Countries holding a registration under ATC A03AD01 (papaverine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Papaverine · ATC A03AD01
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- PAPAVERINE HYDROCHLORIDE
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Country
- Canada (CA)
- ATC code
- A03AD01
- ATC class
- Papaverine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
281 interactions on record for papaverine.
Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Papaverine · interactions on record
281 records
- 216 severe
- 63 moderate
- 2 minor
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Papaverine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPapaverine 200mg/10ml solution for injection vialsSpecial Order
- United StatesPapaverine HydrochlorideNexus Pharmaceuticals, LLC
- NorwayPapaverine renaudinLaboratoire Renaudin
- BelgiumPapaverine HCl Sterop 100 mg/3 mlLaboratoires Sterop
- FinlandPapaverinOy Leiras Finland Ab
- FrancePAPAVERINE RENAUDIN 40 mg/ml, solution injectableLABORATOIRE RENAUDIN
- GermanyPaveron NLinden Arzneimittel-Vertrieb-Gmbh
- PolandPapaverinum hydrochloricum WZFZakłady Farmaceutyczne POLPHARMA S.A.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Papaverine Hcl Sterop
- Bulgaria · Папаверин Актавис, Папаверин Софарма
- Germany · Paveron N
- Denmark · Papaverin Oba
- France · Papaverine Renaudin
- Italy · Papaverina Cloridrato Galenica Senese, Papaverina Cloridrato Monico
- Latvia · Papaverine Sopharma
- Poland · Papaverinum Hydrochloricum Wzf
- Portugal · Papaverina Labesfal
- Romania · Papaverina, Papaverină Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9971a4a-e9bb-40d2-94ac-1a44a6a2c1bb GET /v1/drugs/d9971a4a-e9bb-40d2-94ac-1a44a6a2c1bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00009881",
"form": "LIQUID",
"class": "Human",
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A03AD01",
"schedule": [
"Ethical"
],
"drug_code": "160",
"strengths": [
"65 MG"
],
"ahfs_class": null,
"substances": [
"PAPAVERINE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about papaverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.